That could explain it, but I would think the BP internal
That could explain it, but I would think the BP internal research dept. would look right past the trial design and FDA responses and see what is working with the drug. just because cytodyn is working on combo HIV, does not mean that BP can clearly see the MOA and know they can make this a mono drug or know it is a mono drug. The Covid trials and the FDA letter mean nothing to BP, they can look at the data and know this is all because of trial design and lack of clout/funding to move faster in bigger trials - which they do all the time. they are not influenced but what the FDA does, they are looking at what can happen with the drug and how they want to be involved with it. this is why most MA in the biotech are for phase 2 drugs, not fully approved phase 3 drugs. I can only imagine the window of opportunity for a buy out passed when we got to p3 in HIV. Cytodyn might be too far along. the nash and cancer indications are on target, but i would think a BP wants the whole enchilada or nothing.
4
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Clearwater Analytics Strengthens APAC Leadership Clearwater Analytics (NYSE: CWAN) is making significant strides in the Asia-Pacific region with new leadership appointments and notable award recognitions. Recently, the company appointed George Hindmarsh as the Head of Sales and Business Development for the APAC region. This key move is expected to play a crucial role in...
Continue Reading
Exciting New Addition to Liberty Partners Group Liberty Partners Group is thrilled to announce the entry of David Totaro to its prestigious team. With a wealth of experience in government relations and public affairs, David will officially take on the role of Principal, significantly enhancing the firm's capabilities. David Totaro's Impressive Background David brings vast...
Continue Reading
Hemlo Mining Corp. Launches New Branding and Website New branding unveiled as part of the Company's exciting commencement of trading on TSXV The new logo reflects the Company's mission and values as a Canadian gold producer. Hemlo Mining Corp. (TSXV: HMMC) has officially launched its new logo, branding, and website. This significant development coincides with the first...
Continue Reading
Understanding the Recent Investigation into GSK plc In a notable development, an investigation has been initiated regarding GSK plc. Investors who may have experienced losses related to GSK, or who have questions concerning their rights, are being urged to come forward and seek assistance. This action is being spearheaded by a prominent law firm focused on defending...
Continue Reading
Join the Lawsuit Against PubMatic, Inc. Investors have a significant opportunity to take a stand against PubMatic, Inc. This comes in light of the class action lawsuit initiated by The Schall Law Firm, aimed at holding the company accountable for alleged securities fraud. Those affected by smoking gun revelations regarding misleading statements can participate and...
Continue Reading
